Teva Pharmaceutical Industries announced it will relocate production of its popular painkiller Acamol from Israel to its facility in Ulm, Germany. The move is part of a broader strategy to streamline operations and align Israeli products with European standards. Despite the shift, Teva stated that there will be no layoffs at the Kfar Saba plant, which employs around 1,000 workers. Other versions of the drug, including Acamol Focus, Acamol Cold in gel capsules, and Acamol Forte, will still be manufactured in Israel.